Eu Yan Sang's full-year net profit rises 11% to $18.2 million on robust sales in HK, Malaysia
Full-year net profit for traditional Chinese medicine firm Eu Yan Sang International rose by 11 per cent to $18.2 million compared with a year ago.
Releasing its earnings after markets closed today, the mainboard-listed company said its revenue for the year ended June 30 grew by 13 per cent to $326.9 million compared with the previous financial year.
It said good sales performance in Hong Kong and Malaysia boosted its earnings.
Eu Yan Sang's group chief executive Richard Eu said: "Operating profit of our core markets, namely Hong Kong, Malaysia and Singapore, grew 18 percent year-on-year."